investigated whether combining a vitamin D analog (paricalcitol) and an angiotensin receptor blocker (losartan) leads to more effective inhibition of the renin–angiotensin system and prevention ...
Discover how a new study highlights the transformative potential of Th2 immunity in early cancer intervention.